Medical Devices & Wearable Health Technology / AI Cloud Computing (post-merger)
Strategic Profile
The company develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring systems. Movano's board initiated a process to explore strategic alternatives, including a sale or merger, which led to a definitive Agreement and Plan of Merger with Corvex, Inc., an AI cloud computing company specializing in GPU-accelerated infrastructure.
Cyborg Score Rationale
Movano faces significant regulatory and financial headwinds including delisting risks, negative earnings, minimal market capitalization, and a pending transformational merger with a AI infrastructure company. While the company has innovative wearable technology and FDA clearances, execution challenges and financial distress limit near-term outlook.
Top Insights
The company announced a definitive all-stock merger with Corvex Inc., an AI cloud computing company specializing in GPU-accelerated infrastructure.
The company has announced clinical study results for its wrist-worn cuffless blood pressure prototype, noting accuracy within FDA-recognized standards for wearable, cuffless blood pressure devices.
The company has faced multiple Nasdaq notifications related to bid price, periodic filing timeliness, and stockholders' equity requirements.
Movano Health implemented a 1-for-10 reverse stock split effective October 10, 2025.
Named Competitors
Oura Ring — Finger-based wearable health tracking ring
Apple Watch — Smartwatch with health and wellness monitoring
Whoop Band — Fitness and recovery wearable platform
GPU-Accelerated Cloud Services — AI infrastructure competitors post-merger
Recent Developments
(November 2025) All-stock merger announced with Corvex Inc., an AI cloud computing company